AZYO - Spark Newswire

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

1 minute read

Earnings

Aziyo Biologics: Q2 Earnings Insights

By Benzinga Insights

August 11, 5:27 PM

Aziyo Biologics (NASDAQ:AZYO) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

AZYO

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

August 11, 5:09 AM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG

1 minute read

Aziyo Reaffirms FY22 Total Net Sales Guidance $47M-$50M

By Bill Haddad

May 9, 4:49 PM

Guidance for Full Year 2022 Aziyo is confirming its expectation that total net sales for the full year 2022 will range between $47 to $50 million. Excluding approximately $4.9 million of FiberCel sales in 2021, this

AZYO

16 minute read

Earnings Scheduled For May 9, 2022

By Benzinga Insights

May 9, 4:52 AM

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.

ACM

1 minute read

Earnings

A Preview Of Aziyo Biologics’s Earnings

By Benzinga Insights

May 6, 10:06 AM

Aziyo Biologics (NASDAQ:AZYO) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Aziyo Biologics will report an earnings per share (EPS) of $-0.62.

AZYO